LGR4 is a receptor for RANKL and negatively regulates osteoclast differentiation and bone resorption

NATURE MEDICINE(2016)

引用 268|浏览27
暂无评分
摘要
LGR4 has been identified as a new receptor for RANKL in bone cells where it opposes RANK signaling to inhibit osteoclasts differentiation, and its therapeutic targeting promotes reduced bone loss in three mouse models of osteoporosis.
更多
查看译文
关键词
G protein-coupled receptors,Central control of bone remodelling,Osteoporosis
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要